NASDAQ: MASI - Masimo Corporation

Yield per half year: +1.27%
Sector: Healthcare

Company Analysis Masimo Corporation

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (78.22%) is higher than the sector average (-49.7%).

Disadvantages

  • Price (139.94 $) is higher than fair price (13.94 $)
  • Dividends (0%) are below the sector average (0.5496%).
  • Current debt level 30.39% has increased over 5 years from 0%.
  • The company's current efficiency (ROE=5.97%) is lower than the sector average (ROE=9.61%)

Similar companies

DENTSPLY SIRONA

Amgen

Alexion

ABIOMED

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Masimo Corporation Healthcare Index
7 days 0.8% 2.5% 0.6%
90 days 28.5% -35.8% 8.4%
1 year 78.2% -49.7% 33.9%

MASI vs Sector: Masimo Corporation has outperformed the "Healthcare" sector by 127.92% over the past year.

MASI vs Market: Masimo Corporation has outperformed the market by 44.32% over the past year.

Stable price: MASI is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: MASI with weekly volatility of 1.5% over the past year.

3. Summary of the report

3.1. General

P/E: 78.35
P/S: 3.12

3.2. Revenue

EPS 1.51
ROE 5.97%
ROA 2.68%
ROIC 14.9%
Ebitda margin 12.82%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (139.94 $) is higher than the fair price (13.94 $).

Price is higher than fair: The current price (139.94 $) is 90% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (78.35) is higher than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (78.35) is higher than that of the market as a whole (48.12).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (4.68) is lower than that of the sector as a whole (4.82).

P/BV vs Market: The company's P/BV (4.68) is higher than that of the market as a whole (3.1).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (3.12) is lower than that of the sector as a whole (33.76).

P/S vs Market: The company's P/S indicator (3.12) is lower than that of the market as a whole (10.15).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (27.38) is higher than that of the sector as a whole (-22.12).

EV/Ebitda vs Market: The company's EV/Ebitda (27.38) is higher than that of the market as a whole (18.05).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -11.69% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-11.69%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).

5.4. ROE

ROE vs Sector: The company's ROE (5.97%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (5.97%) is lower than that of the market as a whole (10.88%).

5.5. ROA

ROA vs Sector: The company's ROA (2.68%) is higher than that of the sector as a whole (0.3359%).

ROA vs Market: The company's ROA (2.68%) is lower than that of the market as a whole (6.5%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (14.9%) is higher than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (14.9%) is higher than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (30.39%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 30.39%.

Excess of debt: The debt is not covered by net income, percentage 1133.99%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5496%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.63.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
13.11.2024 Levy Tao
EVP, Bus Dev
Purchase 161.07 4 832 100 30 000
08.08.2024 KIANI JOE E
CEO and Chairman of the Board
Purchase 37.84 8 769 340 231 748
26.04.2024 REYNOLDS CRAIG B
Director
Sale 136.17 5 446 800 40 000
26.04.2024 REYNOLDS CRAIG B
Director
Purchase 23.04 921 600 40 000
10.01.2022 Mikkelson Adam
Director
Sale 250.01 150 006 600

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Masimo Corporation

9.3. Comments